ANI Pharmaceuticals Reports Record First Quarter 2024 Financial Results and Reiterates 2024 Guidance
BAUDETTE, Minn., May 10, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today…
59,990$
0,77%
Echtzeit-Aktienkurs ANI Pharmaceuticals Inc.
Bid:
Ask:
Nachrichten zur ANI Pharmaceuticals Inc. Aktie
ANI Pharmaceuticals (ANIP) to Post Q1 Earnings: Whats in Store?
ANI Pharmaceuticals (ANIP) revenues in the first quarter of 2024 are likely to have been driven by increased sales of…
ANI Pharmaceuticals to Discuss First Quarter 2024 Financial Results on May 10, 2024, at 8:30 a.m. ET
BAUDETTE, Minn., April 18, 2024 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (“ANI” or the “Company”) (NASDAQ: ANIP) today…
Nika Pharmaceuticals, Inc. (NKPH) Purchased the Technologies for Three Drugs in Tablet Form and One Dietary Supplement
Nika Pharmaceuticals, Inc. (NKPH) announces the purchase of technologies for production of three generic drugs in tablet form and one…
GMAB: 3 Biotech Stocks Gaining Altitude and Interest
This year, the biotech industry anticipates a resurgence with increased M&A, FDA approvals, and AI-driven innovations. Given the industry’s rosy…
Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc.
Nika Pharmaceuticals, Inc. (OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc., effective as of March 1, 2024.…
ANI Pharmaceuticals, Inc. (ANIP) Q4 2023 Earnings Call Transcript
…